These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20592323)

  • 1. Topiramate-induced myoclonus and psychosis during migraine prophylaxis.
    Miller AD; Prost VM; Bookstaver PB; Gaines KJ
    Am J Health Syst Pharm; 2010 Jul; 67(14):1178-80. PubMed ID: 20592323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration.
    Oulis P; Potagas C; Masdrakis VG; Thomopoulos Y; Kouzoupis AV; Soldatos CR
    Clin Neuropharmacol; 2008; 31(6):366-7. PubMed ID: 19050415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auditory hallucinations associated with topiramate.
    Matthews SC; Miller BP
    J Clin Psychiatry; 2001 Aug; 62(8):653. PubMed ID: 11561939
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychosis following treatment with topiramate].
    Verhoeven WM; Boermans JA; van der Heijden FM; Tuinier S
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2093-5. PubMed ID: 12448965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute psychotic symptoms induced by topiramate.
    Khan A; Faught E; Gilliam F; Kuzniecky R
    Seizure; 1999 Jun; 8(4):235-7. PubMed ID: 10452922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate-induced confusion following a single ingestion of 400 mg.
    Pierson MD; Muzyk AJ; Lockamy M; Preud'homme XA
    Gen Hosp Psychiatry; 2010; 32(6):647.e1-3. PubMed ID: 21112462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible tremor, myoclonus, and fasciculations associated with topiramate use for migraine.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2006; 29(3):157-9. PubMed ID: 16772816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial.
    Lai KL; Niddam DM; Fuh JL; Chen SP; Wang YF; Chen WT; Wu JC; Wang SJ
    Acta Neurol Scand; 2017 Apr; 135(4):476-483. PubMed ID: 27306581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
    Afshari D; Rafizadeh S; Rezaei M
    Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical use of topiramate for migraine prevention.
    Brandes JL
    Headache; 2005 Apr; 45 Suppl 1():S66-73. PubMed ID: 15833092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate-induced psychosis.
    Kober D; Gabbard GO
    Am J Psychiatry; 2005 Aug; 162(8):1542. PubMed ID: 16055782
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperventilation and cerebrospinal fluid acidosis caused by topiramate.
    Montcriol A; Meaudre E; Kenane N; Asencio Y; Bordes J; Palmier B
    Ann Pharmacother; 2008 Apr; 42(4):584-7. PubMed ID: 18420530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight variations in patients receiving topiramate migraine prophylaxis in a tertiary care setting.
    Krymchantowski A; Tavares C
    MedGenMed; 2004 Jul; 6(3):48. PubMed ID: 15520672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis.
    Von Seggern RL; Mannix LK; Adelman JU
    Headache; 2002 Sep; 42(8):804-9. PubMed ID: 12390645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate monotherapy use in women with and without epilepsy: pregnancy and neonatal outcomes.
    Castilla-Puentes R; Ford L; Manera L; Kwarta RF; Ascher S; Li Q
    Epilepsy Res; 2014 May; 108(4):717-24. PubMed ID: 24598456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate-induced intractable cough during migraine prophylaxis.
    Maggioni F; Mampreso E; Mainardi F; Lisotto C; Malvindi ML; Zanchin G
    Headache; 2010 Feb; 50(2):301-4. PubMed ID: 19751366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.